Scientific Planning Committee

Thurayya Arayssi, MD, Anna Halama, PhD, Kadhija Ziana Vamanjoor, BDS, MFDS, RCS, Mark D Santos, RN, BSN, CNS, Nicola Lategan, RT, BSc, Salman Al Jerdi, MD, Deema Al-Sheikhly, MRes, MEHP, Mohamed Ali Hammami, MBA, Aicha Hind Rifai, MD, Nafe Atari, Mushtaq Bukhari, Mahmood Dualeh, MBA/MSTIS, MBA, MSTIS, PMP, Moune Jabre, MD, Frantzeska Gkioka, MBA

Have no relevant financial/non-financial relationships with any for-profit/not-for-profit organizations to disclose.
Will not be discussing unlabeled/unapproved use of drugs or products.

Scientific Planning Committee: Leena Amine, PharmD
Disclosed the following financial relationship:
Consulting fee, Wolters Kluwer
All of the relevant financial/non-financial relationships with for-profit/not-for-profit organizations have been mitigated.
Will not be discussing unlabeled/unapproved use of drugs or products.

Scientific Planning Committee: Liam J Fernyhough, MD
Disclosed the following financial relationship:
Flights and accommodation paid for conference-Biomarin
Honoraria-Roche
All of the relevant financial/non-financial relationships with any for-profit/not-for-profit organizations have been mitigated.
The financial/non-financial relationships are not relevant.
Will not be discussing unlabeled/unapproved use of drugs or products.

Scientific Planning Committee: Jamie Gray, MLS, MS
Disclosed the following financial relationship:
Stocks or stock options, excluding diversified mutual funds-Colgate-Palmolive|Stocks or stock options, excluding diversified mutual funds-Proctor & Gamble|Stocks or stock options, excluding diversified mutual funds-Intuitive Surgical Inc.
All of the relevant financial/non-financial relationships with any for-profit/not-for-profit organizations have been mitigated.
Will not be discussing unlabeled/unapproved use of drugs or products.

Course Directors

Thurayya Arayssi, MD, Anna Halama, PhD
Have no relevant financial/non-financial relationships with any for-profit/not-for-profit organizations to disclose.
Will not be discussing unlabeled/unapproved use of drugs or products.

Course Faculty/Moderators

Thurayya Arayssi, MD, Anna Halama, PhD, Javaid Sheikh, MD, Abdullatif Al-Khal, MD, Ibrahim Janahi, MD,  Sanjay Desai, MD, MACP, Kirsten Ostherr, PhD, Marcos S Rojas Pino, MD,  Jonathan St George, MD, Lauren A Toomer, MFA, Matteo Zallio, PharmD, Abdulaziz Yousef, Bachelor in Business Administrations, Deema Al-Sheikhly, MRes, MEHP, Stella Major, MBBS, Laudy Mattar, Educator, Salman Al Jerdi, MD, Aicha Hind Rifai, MD, Mohamed Ali Hammami, MBA, Shaymaa Dib, Master Degree, Nasnass Nassir, BHMS,  Monsur Ahmmad, BBS
Have no relevant financial/non-financial relationships with any for-profit/not-for-profit organizations to disclose.
Will not be discussing unlabeled/unapproved use of drugs or products.

Course Faculty/Moderators: Nada OBrien, PhD
Disclosed the following financial relationship:
Employment, Magic Leap
All of the relevant financial/non-financial relationships with any for-profit/not-for-profit organizations have been mitigated.
Will not be discussing unlabeled/unapproved use of drugs or products.

Course Faculty/Moderators: Effy Vayena, PhD
Disclosed the following financial relationship:
Honoraria-Bayer
Honoraria-Merck & Roche
All of the relevant financial/non-financial relationships with any for-profit/ not-for-profit organizations have been mitigated.
The financial/non-financial relationships are not relevant.
Will not be discussing unlabeled/unapproved use of drugs or products.

Course Faculty/Moderators: Liam J Fernyhough, MD
Disclosed the following financial relationship:
Flights and accommodation paid for conference-Biomarin 
Honoraria-Roche
All of the relevant financial/non-financial relationships with any for-profit/not-for-profit organizations have been mitigated.
The financial/non-financial relationships are not relevant.
Will not be discussing unlabeled/unapproved use of drugs or products.

Independent Content Reviewer

Anna Halama, PhD

Have no relevant financial/non-financial relationships with any for-profit/not-for-profit organizations to disclose.
Will not be discussing unlabeled/unapproved use of drugs or products.

Administrative Contact

Aaliya Chougle, MA
Have no relevant financial/non-financial relationships with any for-profit/not-for-profit organizations to disclose.
Will not be discussing unlabeled/unapproved use of drugs or products.
The scientific planning committee has reviewed all disclosed financial relationships of speakers, moderators, facilitators and/or authors in advance of this CPD activity and has implemented procedures to manage any potential or real conflicts of interest.

Disclosure of Relationships/Content Validity

It is the policy of Weill Cornell Medicine-Qatar to adhere to Ministry of Public Health's Department of Healthcare Professions (DHP) and Accreditation Council for Continuing Medical Education (ACCME) Criteria, Policies, and Standards for Commercial Support and content validation in order to ensure fair balance, independence, objectivity, and scientific rigor in all its sponsored programs. All faculty participating in sponsored programs are expected to disclose relevant financial relationships pertaining to their contribution to the activity, and any discussions of off-label or investigational uses of approved commercial products or devices, or of any products or devices not yet approved in the United States and elsewhere. WCM-Q CME/CPD activities are intended to be evidence-based and free of commercial bias. 

Evaluation 

An anonymous evaluation will be conducted online and can be found in your “My CE” tab of the WCM-Q CloudCME portal (https://wcmq.cloud-cme.com). All participants are required to complete the evaluation in order to qualify for a certificate.The evaluation allows us to assess the degree to which the activity met its objectives.It will also guide the planning of future activities and inform decisions about improving the educational program.

Accreditation and Credit Designation

	ACCME Accreditation Statement Weill Cornell Medicine-Qatar is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. ACCME Credit Designation Statement The Weill Cornell Medicine-Qatar designates this live activity for a maximum of 8.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
	DHP Accreditation Statement Weill Cornell Medicine-Qatar is accredited as a provider of Continuing Medical Education (CME) and Continuing Professional Development (CPD) by the Department of Healthcare Professions of the Ministry of Public Health. DHP Credit Designation Statement This activity is an Accredited Group Learning Activity (Category 1) as defined by the Ministry of Public Health's Department of Healthcare Professions-Accreditation Section and is approved for a maximum of 8.25 hours. The scientific planning committee has reviewed all disclosed financial relationships of speakers, moderators, facilitators and/or authors in advance of this CPD activity and has implemented procedures to manage any potential or real conflicts of interest.